The MERIT ( Maraviroc versus Efavirenz in Treatment-Naive Patients ) study compared maraviroc and efavirenz , both with zidovudine-lamivudine , in antiretroviral-naive patients with R5 human immunodeficiency virus type 1 ( HIV-1 ) infection .
